RecruitingNCT05128006

Direct-to-patient Teledermatology and Computer-assisted Diagnosis

Improving Dermatology Access by Direct-to-Patient Teledermatology and Computer-Assisted Diagnosis


Sponsor

VA Office of Research and Development

Enrollment

63,200 participants

Start Date

Nov 7, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

This study will examine access to dermatology care. The operational partner will implement a direct-to-new patient teledermatology clinical care pathway while the research will study the effects of that implementation, use data associated with deployment to develop and test an Artificial Intelligence system, and understand key stakeholders' attitudes regarding and readiness for remote dermatology care.


Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • New patient referrals to dermatology at San Francisco, Decatur, and Aurora from 2021-2025

Exclusion Criteria3

  • Patients who are not dermatology patients
  • Dermatology patients who are not seen at San Francisco, Decatur, and Aurora
  • Dermatology patients at San Francisco, Decatur, and Aurora who have visits only before 2021 or after 2025

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNew patient teledermatology visit

new patient teledermatology visits


Locations(3)

San Francisco VA Medical Center, San Francisco, CA

San Francisco, California, United States

Rocky Mountain Regional VA Medical Center, Aurora, CO

Aurora, Colorado, United States

Atlanta VA Medical and Rehab Center, Decatur, GA

Decatur, Georgia, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05128006